MedAdvisor Limited (ASX: MDR) Webcast Replay

5th April, 2023

MedAdvisor Limited (ASX: MDR) is an Australian medtech and global leader in medication management solutions with a global network of nearly 38,000 pharmacies reaching 235 million patients

As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Rick Ratliff, provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 5th April 2023 at 12pm (AEST).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team



CEO - MedAdvisor Limited (ASX: MDR)

MedAdvisor provides simple medication communication solutions to improve patients’ awareness and understanding of their medications. The company’s mobile app, pharmacy software and patient engagement solutions encompass a comprehensive medication adherence platform addressing a US$600 billion problem. In H1 FY23, MedAdvisor earned $64.1 million and posted a record positive EBITDA of $8.6 million (up $13.1 million on H1 FY22). Operating within a total addressable market of US$16 billion (as at March 2023), the company aims to leverage its digital capabilities and accelerate expansion further into the global market.

latest other webcasts

Felix Gold (ASX: FXG) Webcast Replay

Prescient Therapeutics (ASX: PTX) Webcast Replay

Felix Gold (ASX: FXG) Webcast Replay

Speak to the Reach Markets team

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.